Finanzen von Cutera Inc (CUTR)CUTRCutera Inc

Cutera Inc (CUTR) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Products, accounting for 69.5% of total sales, equivalent to $23.90M. Other significant revenue streams include Systems and Service. Understanding this composition is critical for investors evaluating how CUTR navigates market cycles within the Advanced Medical Equipment & Technology industry.

Evaluating the bottom line, Cutera Inc maintains a gross margin of 5.58%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -111.44%, while the net margin is -120.06%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively CUTR converts its operational activities into shareholder value.

In the context of the broader market, CUTR competes directly with industry leaders such as VERO and NDRA. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, CUTR's gross margin of 5.58% stands against VERO's 64.00% and NDRA's N/A. Such benchmarking helps identify whether Cutera Inc is trading at a premium or discount relative to its financial performance.